>北美健康筛查市场,按测试类型(胆固醇测试、糖尿病测试、癌症筛查、一般体检、性病、血压测试等)、套餐类型(基本健康筛查、老年人概况、女性健康检查、男性健康检查、心脏检查糖尿病检查等)、面板类型(多测试面板和单测试面板)、样本类型(血液、尿液、血清、唾液等)、技术(免疫测定、医学成像、QPCR(定量聚合酶链反应)、Q-FISH(定量荧光原位杂交)、TRF(末端限制性片段)、STELA(单端粒长度分析)等)、疾病(心血管疾病、代谢紊乱、癌症、炎症性疾病、肌肉骨骼疾病、神经系统疾病、丙型肝炎并发症、免疫相关疾病等)划分,样本采集地点(医院、家庭、诊断实验室、办公室和其他)、分销渠道(直接招标、零售销售和其他)、国家(美国、加拿大和墨西哥)行业趋势和预测到 2028 年。
市场分析与洞察:北美健康检查市场
北美健康筛查市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在 2021 年至 2028 年的预测期内,该市场的复合年增长率为 12.1%,预计到 2028 年将达到 285 万美元。慢性病数量的增加、老年人口的增加以及对疾病早期发现和治疗认识的提高是预测期内推动市场需求的主要驱动力。
健康筛查是早期发现特定疾病的重要方法。筛查测试通常用于预防医学,以确定个人是否表现出疾病风险因素的早期迹象。可以通过筛查发现的疾病包括癌症、糖尿病、高胆固醇、高血压和骨质疏松症。慢性病数量激增、老年人口增加、对疾病早期发现和治疗的认识不断提高,推动了健康筛查市场的增长。
人们对疾病早期发现和治疗意识的增强以及医疗支出的增加,增加了对健康筛查的需求,并成为市场发展的驱动力
由于健康筛查的有效性,对健康筛查的需求不断增长,服务提供商的数量不断增加,以及私人和公共机构对健康筛查的宣传活动不断加强,这些都推动了预测期内健康筛查市场的增长,并带来了机遇。然而,筛查测试的高成本可能会阻碍预测期内市场的增长。
北美健康筛查市场报告提供了市场份额、新发展和产品线分析的详细信息,国内和本地化市场参与者的影响,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况,请联系我们获取分析师简报;我们的团队将帮助您创建收入影响解决方案,以实现您的预期目标。
北美健康检查市场范围和市场规模
北美健康筛查市场根据八个显著的细分市场进行细分:测试类型、包装类型、面板类型、样本类型、技术、条件、样本收集地点和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。
- 根据测试类型,北美健康筛查市场细分为胆固醇测试、糖尿病测试、癌症筛查、常规体检、性病、血压测试等。2021 年,胆固醇测试细分市场预计将占据市场主导地位,因为胆固醇相关疾病的患病率不断上升,不良的饮食习惯也增加了这些测试的风险。
- 根据套餐类型,北美健康筛查市场细分为基本健康筛查、老年人概况、女性健康检查、男性健康检查、心脏检查、糖尿病检查等。2021 年,基本健康筛查细分市场预计将占据市场主导地位,因为市场竞争日益激烈,不同的实验室提供套餐以吸引患者在其实验室接受筛查。
- 根据面板类型,北美健康筛查市场分为多检测面板和单检测面板。2021 年,多检测面板细分市场预计将占据市场主导地位,因为各种实验室和诊断中心都使用多检测面板进行筛查,而在当前情况下,疾病通过症状和发病相互关联,这增加了使用多面板同时筛查不同检测的需求
- 根据样本类型,北美健康筛查市场分为血液、尿液、血清、唾液等。预计到 2021 年,血液将占据市场主导地位,因为它是最简单、最方便的筛查和诊断方法。
- 根据技术,北美健康筛查市场细分为免疫测定、医学成像、QPCR(定量聚合酶链反应)、Q-FISH(定量荧光原位杂交)、TRF(末端限制性片段)、STELA(单端粒长度分析)等。2021 年,免疫测定领域预计将占据市场主导地位,因为免疫测定在输血、基因疗法、植入手术、传染病筛查等各种应用中都有所贡献,而且美国和加拿大是新技术的主要市场,并且相信现有技术的进步也是该领域增长的主要因素。
- 根据病情,北美健康筛查市场细分为心血管疾病、代谢紊乱、癌症、炎症性疾病、肌肉骨骼疾病、神经系统疾病、丙型肝炎并发症、免疫相关疾病等。2021 年,北美地区心血管疾病的患病率很高,因为几乎 3% 的人有新发或复发性心脏病,这使得这一细分市场在预测期内有所增长。
- 根据样本采集地点,北美健康筛查市场分为医院、家庭、诊断实验室、办公室和其他。2021 年,医院部门预计将占据市场主导地位,因为医院拥有诊断和治疗疾病的所有设施。
- 根据分销渠道,北美健康筛查市场分为直接招标、零售和其他。2021 年,由于健康筛查项目整体销售额的增加,预计直接招标部分将占据市场主导地位。
北美 健康检查市场国家层面分析
分析了北美健康筛查市场,并提供了有关测试类型、包装类型、面板类型、样本类型、技术、条件、样本收集地点和分销渠道的市场规模信息。北美健康筛查市场报告涵盖的国家包括美国、加拿大和墨西哥。
由于老年人口的增加以及人们对疾病早期发现和治疗意识的增强,预计北美地区的美国将在 2021 年至 2028 年的预测期内以最高的增长率增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。
全球范围内癌症、糖尿病、心血管疾病等慢性病发病率的上升以及老年人口的增加,推动了北美健康筛查市场的增长
北美健康筛查市场还为您提供有关每个国家筛查产品行业增长的详细市场分析,包括药品销售、进步、技术和监管环境变化对健康筛查市场的支持。数据涵盖 2010 年至 2019 年的历史时期。
竞争格局和北美健康检查 市场份额分析
北美健康筛查市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对氟化二胺银 (SDF) 市场的关注有关
北美心脏筛查市场的主要公司有 Quest Diagnostics Incorporated、Laboratory Corporation of America、Sonic Healthcare Limited、Exact Sciences Corporation、Healius Limited、GRAIL、Eurofins Scientific、、SYNLAB International GmbH、UNILABS、LabPLUS、BioReference Laboratories、、ACM Global Laboratories、Cerba Healthcare、Quidel Corporation、Innova Medical Group、AMEDES Holding GmbH、RadNet, Inc.、Natera, Inc.、Trinity Biotech、Nuffield Health、RepeatDx、NeoGenomics Laboratories、HU Group Holdings, Inc.、Lifelabs、ARUP Laboratories、Q2 Solutions、Genova Diagnostics、Life Length、DNA Labs India、、Telomere Diagnostics、Charles River Laboratories、Ambry Genetics、SpectraCell Laboratories, Inc.、Dr. Lal PathLabs 等。
世界各地的公司还发起了许多活动、协议和网络研讨会,这也加速了北美健康检查市场的发展。
例如,
- 2021年4月,Ambry Genetics宣布已在2021ACMG年度临床遗传学会议上发表演讲。这为该公司提供了一个展示其商业理念的平台。
- 2021 年 9 月,ARUP 实验室宣布与 Air med 合作,通过向航班和其他设施提供血液供应,为患者提供医疗服务。这将增加服务提供商的患者数量,从而在预测期内为实验室提供帮助。
合作、产品发布、业务扩展、奖励和认可、合资企业和其他市场参与者增强了公司在北美健康筛查市场的市场,这也有利于该组织改善其健康筛查药物的供应。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA HEALTH SCREENING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TEST TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 DISTRIBUTION CHANNELUSER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATIONS
5.1 WORLD HEALTH ORGANIZATION
5.2 NORTH AMERICA
5.3 EUROPE
6 INDUSTRIAL INSIGHTS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF CHRONIC DISEASES
7.1.2 GROWING GERIATRIC POPULATION
7.1.3 GOVERNMENT INITIATIVES UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
7.1.4 RISING PER CAPITA INCOME AND HEALTHCARE EXPENDITURE
7.1.5 GRWOING NUMBER OF SCREENING PROGRAMS WORLDWIDE
7.2 RESTRAINTS
7.2.1 SCRACITY OF TECHNICALLY-SKILLED PROFESSIONALS
7.2.2 RISKS ASSOCIATED WITH SCREENING
7.2.3 LACK OF ACCESSIBILITY
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEALTH SCREENING
7.3.2 ACQUSITIONS AND MERGERS AMONG THE MARKET
7.3.3 NEW PRODUCT LAUNCHES IN THE MARKET
7.4 CHALLENGES
7.4.1 HIGHER COST OF HEALTH SCREENING
7.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING SCREENING TESTS
8 COVID-19 IMPACT ON NORTH AMERICA HEALTH SCREENING MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 NORTH AMERICA HEALTH SCREENING MARKET, BY TEST TYPE
9.1 OVERVIEW
9.2 CHOLESTEROL TESTS
9.2.1 TOTAL CHOLESTEROL TESTS
9.2.2 TRIGLYCERIDES
9.2.3 LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
9.2.4 HIGH-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
9.3 DIABETES TEST
9.3.1 FASTING/RANDOM BLOOD SUGAR TEST
9.3.2 A1C TEST
9.3.3 GLUCOSE TOLERANCE TEST
9.4 CANCER SCREENING
9.4.1 LIQUID BIOPSY
9.4.2 MAMMOGRAMS, OSTEOPOROSIS, BREAST MRI AND PAP SMEAR TESTS
9.4.3 LOW-DOSE HELICAL COMPUTED TOMOGRAPHY
9.4.4 COLORECTAL CANCER SCREENING TEST (STOOL TESTS, SIGMOIDOSCOPY, COLONOSCOPY, BLOOD-BASED DNA TEST, DOUBLE-CONTRAST BARIUM ENEMA (DCBE), AND SINGLE-SPECIMEN GFOBT)
9.4.5 PROSTATE SPECIFIC ANTIGEN (PSA) TEST
9.4.6 NEW-EARLY DETECTION CANCER TESTS
9.4.7 ALPHA FETOPROTEIN BLOOD TEST
9.4.8 CA-125 TEST
9.4.9 OTHERS
9.5 GENERAL CHECK UP TEST
9.5.1 REGULAR CHECK UP
9.5.1.1 REGULAR BLOOD TEST
9.5.1.2 X-RAYS
9.5.1.3 ECG
9.5.1.4 FECALYSIS
9.5.1.5 URINALYSIS
9.5.1.6 BMI
9.5.1.7 OTHERS
9.5.2 EYE CHECK UP
9.5.3 DENTAL TEST
9.5.4 HEARING TEST
9.6 STD’S
9.6.1 CHLAMYDIA
9.6.2 GONORRHEA
9.6.3 HPV
9.6.4 HIV
9.6.5 OTHERS
9.7 BLOOD PRESSURE TEST
9.8 OTHERS
9.8.1 LIVER FUNCTION TESTS
9.8.2 KIDNEY PROFILE
9.8.3 OTHERS
10 NORTH AMERICA HEALTH SCREENING MARKET, BY PANEL TYPE
10.1 OVERVIEW
10.2 MULTI-TEST PANELS
10.3 SINGLE-TEST PANELS
10.3.1 INFLAMMATION TESTS
10.3.2 OXIDATIVE STRESS TESTS
10.3.3 HEAVY METAL TESTS
10.3.4 TELOMERE
11 NORTH AMERICA HEALTH SCREENING MARKET, BY PACKAGE TYPE
11.1 OVERVIEW
11.2 BASIC HEALTH SCREENING
11.3 SENIOR CITIZEN PROFILE
11.4 WOMEN HEALTH CHECK
11.5 MEN HEALTH CHECK
11.6 HEART CHECK
11.7 DIABETES CHECK
11.8 OTHERS
12 NORTH AMERICA HEALTH SCREENING MARKET, BY SAMPLE TYPE
12.1 OVERVIEW
12.2 BLOOD
12.3 URINE
12.4 SERUM
12.5 SALIVA
12.6 OTHERS
13 HEALTH SCREENING MARKET, BY TECHNOLOGY
13.1 OVERVIEW
13.2 IMMUNOASSAYS
13.3 MEDICAL IMAGING
13.4 QPCR
13.4.1 MMQPCR (MONOCHROME MULTIPLEX QPCR)
13.4.2 ATLQPCR (ABSOLUTE TELOMERE LENGTH QPCR)
13.5 Q-FISH
13.5.1 PRINS (PRIMED IN SITU SUBTYPE OF Q-FISH)
13.5.2 FLOW-FISH
13.5.3 HT Q-FISH (HIGH THROUGHPUT Q-FISH)
13.6 TRF (TERMINAL RESTRICTION FRAGMENT)
13.7 STELA (SINGLE TELOMERE LENGTH ANALYSIS)
13.8 OTHERS
14 NORTH AMERICA HEALTH SCREENING MARKET, BY CONDITION
14.1 OVERVIEW
14.2 CARDIOVASCULAR DISEASE
14.2.1 CORONARY HEART DISEASE
14.2.2 ATHEROSCLEROSIS
14.3 METABOLIC DISORDERS
14.3.1 DIABETES MELLITUS
14.3.2 OBESITY
14.4 CANCER
14.5 INFLAMMATORY CONDITIONS
14.5.1 AUTOIMMUNE CONDITIONS
14.5.2 ALLERGIES
14.5.3 ARTHRITIS
14.5.4 ASTHMA
14.5.5 INFLAMMATORY DIGESTIVE PROBLEMS
14.6 MUSCULOSKELETAL DISORDERS
14.6.1 OSTEOPOROSIS
14.6.2 RHEUMATOID ARTHRITIS
14.7 NEUROLOGICAL CONDITIONS
14.7.1 CHRONIC STRESS
14.7.2 ALZHEIMER'S DISEASE
14.8 IMMUNOLOGY-RELATED CONDITIONS
14.9 HEPATITIS C COMPLICATIONS
14.1 OTHERS
15 HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDERS
15.3 RETAIL SALES
15.4 OTHERS
16 NORTH AMERICA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES
16.1 OVERVIEW
16.2 HOSPITAL
16.2.1 ACUTE CARE HOSPITALS
16.2.2 LONG-TERM CARE HOSPITALS
16.2.3 NURSING FACILITIES
16.2.4 REHABILITATION CENTERS
16.3 HOME
16.4 DIAGNOSTIC LABORATORIES
16.5 OFFICES
16.6 OTHERS
17 NORTH AMERICA HEALTH SCREENING MARKET, BY REGION
17.1 NORTH AMERICA
17.1.1 U.S.
17.1.2 CANADA
17.1.3 MEXICO
18 NORTH AMERICA HEALTH SCREENING MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 QUEST DIAGNOSTICS INCORPORATED
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 SONIC HEALTHCARE LIMITED
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.3 LABORATORY CORPORATION OF AMERICA
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 COMPANY SHARE ANALYSIS
20.3.4 PRODUCT PORTFOLIO
20.3.5 RECENT DEVELOPMENT
20.4 EUROFINS SCIENTIFIC
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENTS
20.5 EXACT SCIENCES CORPORATION
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANALYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENTS
20.6 ACM NORTH AMERICA LABORATORIES
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 AMEDES
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 AMBRY GENETICS
20.8.1 COMPANY SNAPSHOT
20.8.2 SERVICE PORTFOLIO
20.8.3 RECENT DEVELOPMENTS
20.9 ARUP LABORATORIES
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 BIOREFRENCE LABORATORIES
20.10.1 COMPANY SNAPSHOT
20.10.2 REVENUE ANALYSIS
20.10.3 PRODUCT PORTFOLIO
20.10.4 RECENT DEVELOPMENTS
20.11 CHARLES RIVER
20.11.1 COMPANY SNAPSHOT
20.11.2 REVENUE ANALYSIS
20.11.3 PRODUCT PORTFOLIO
20.11.4 RECENT DEVELOPMENTS
20.12 CERBA HEALTHCARE
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 DNA LABS INDIA
20.13.1 COMPANY SNAPSHOT
20.13.2 SERVICE PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 DR LAL PATH LABS
20.14.1 COMPANY SNAPSHOT
20.14.2 REVENUE ANALYSIS
20.14.3 PRODUCT PORTFOLIO
20.14.4 RECENT DEVELOPMENT
20.15 GENOVA DIGNOSTICS
20.15.1 COMPANY SNAPSHOT
20.15.2 SERVICE PORTFOLIO
20.15.3 RECENT DEVELOPMENT
20.16 GRAIL
20.16.1 COMPANY SNAPSHOT
20.16.2 SERVICE PORTFOLIO
20.16.3 RECENT DEVELOPMENTS
20.17 HEALIUS LIMITED
20.17.1 COMPANY SNAPSHOT
20.17.2 REVENUE ANALYSIS
20.17.3 PRODUCT PORTFOLIO
20.17.4 RECENT DEVELOPMENTS
20.18 H.U. GROUP HOLDINGS, INC.
20.18.1 COMPANY SNAPSHOT
20.18.2 REVENUE ANALYSIS
20.18.3 PRODUCT PORTFOLIO
20.18.4 RECENT DEVELOPMENTS
20.19 INNOVA MEDICAL GROUP
20.19.1 COMPANY SNAPSHOT
20.19.2 PRODUCT PORTFOLIO
20.19.3 RECENT DEVELOPMENT
20.2 LABPLUS
20.20.1 COMPANY SNAPSHOT
20.20.2 PRODUCT PORTFOLIO
20.20.3 RECENT DEVELOPMENT
20.21 LIFELABS
20.21.1 COMPANY SNAPSHOT
20.21.2 SERVICE PORTFOLIO
20.21.3 RECENT DEVELOPMENTS
20.22 LIFE LENGTH
20.22.1 COMPANY SNAPSHOT
20.22.2 SERVICE PORTFOLIO
20.22.3 RECENT DEVELOPMENT
20.23 NATERA, INC.
20.23.1 COMPANY SNAPSHOT
20.23.2 REVENUE ANALYSIS
20.23.3 PRODUCT PORTFOLIO
20.23.4 RECENT DEVELOPMENTS
20.24 NEOGENOMICS LABORATORIES
20.24.1 COMPANY SNAPSHOT
20.24.2 REVENUE ANALYSIS
20.24.3 PRODUCT PORTFOLIO
20.24.4 RECENT DEVELOPMENTS
20.25 NUFFIELD HEALTH
20.25.1 COMPANY SNAPSHOT
20.25.2 PRODUCT PORTFOLIO
20.25.3 RECENT DEVELOPMENT
20.26 Q2 SOLUTIONS
20.26.1 COMPANY SNAPSHOT
20.26.2 SERVICE PORTFOLIO
20.26.3 RECENT DEVELOPMENTS
20.27 QUIDEL CORPORATION
20.27.1 COMPANY SNAPSHOT
20.27.2 REVENUE ANALYSIS
20.27.3 PRODUCT PORTFOLIO
20.27.4 RECENT DEVELOPMENTS
20.28 REPEATDX
20.28.1 COMPANY SNAPSHOT
20.28.2 PRODUCT PORTFOLIO
20.28.3 RECENT DEVELOPMENT
20.29 SONIC HEALTHCARE LIMITED
20.29.1 COMPANY SNAPSHOT
20.29.2 REVENUE ANALYSIS
20.29.3 PRODUCT PORTFOLIO
20.29.4 RECENT DEVELOPMENTS
20.3 SPECTRACELL LABORATORIES, INC.
20.30.1 COMPANY SNAPSHOT
20.30.2 SERVICE PORTFOLIO
20.30.3 RECENT DEVELOPMENT
20.31 SYNLAB INTERNATIONAL GMBH
20.31.1 COMPANY SNAPSHOT
20.31.2 PRODUCT PORTFOLIO
20.31.3 RECENT DEVELOPMENT
20.32 TELOMERE DIAGNOSTICS
20.32.1 COMPANY SNAPSHOT
20.32.2 SERVICE PORTFOLIO
20.32.3 RECENT DEVELOPMENT
20.33 TRINITY BIOTECH
20.33.1 COMPANY SNAPSHOT
20.33.2 REVENUE ANALYSIS
20.33.3 PRODUCT PORTFOLIO
20.33.4 RECENT DEVELOPMENT
20.34 UNILABS
20.34.1 COMPANY SNAPSHOT
20.34.2 PRODUCT PORTFOLIO
20.34.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
表格列表
TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)
TABLE 2 NEW CANCER CASES FOR AGE 85+ IN U.S.
TABLE 3 ACCORDING TO THE UNITED NATIONS, IN 2019, THE TOTAL POPULATION OF AGED PEOPLE ABOVE 65 WAS 703 MILLION AND IS EXPECTED TO REACH 1.5 BILLION BY 2050.
TABLE 4 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)
TABLE 5 NORTH AMERICA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA DIABETES TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA CANCER SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA STD’S IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA STD’S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA BLOOD PRESSURE TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA MULTI-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA BASIC HEALTH SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA SENIOR CITIZEN PROFILE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA WOMEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA MEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA HEART CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA DIABETES CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA BLOOD IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA URINE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA SERUM IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA SALIVA IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA IMMUNOASSAYS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA MEDICAL IMAGING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA QPCR IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA Q-FISH IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA Q-FISH IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA TRF (TERMINAL RESTRICTION FRAGMENT) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA STELA (SINGLE TELOMERE LENGTH ANALYSIS) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 NORTH AMERICA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 52 NORTH AMERICA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA CANCER IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 54 NORTH AMERICA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 NORTH AMERICA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 56 NORTH AMERICA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 57 NORTH AMERICA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 58 NORTH AMERICA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 59 NORTH AMERICA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 60 NORTH AMERICA IMMUNOLOGY-RELATED CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 61 NORTH AMERICA HEPATITIS-C COMPLICATIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 62 NORTH AMERICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 63 NORTH AMERICA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 NORTH AMERICA DIRECT TENDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 65 NORTH AMERICA RETAIL SALES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 66 NORTH AMERICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 67 NORTH AMERICA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 68 NORTH AMERICA HOSPITAL IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 69 NORTH AMERICA HOSPITAL IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 70 NORTH AMERICA HOME IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 71 NORTH AMERICA DIAGNOSTIC LABORATORIES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 72 NORTH AMERICA OFFICES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 73 NORTH AMERICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 74 NORTH AMERICA HEALTH SCREENING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 75 NORTH AMERICA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 76 NORTH AMERICA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 77 NORTH AMERICA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 78 NORTH AMERICA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 79 NORTH AMERICA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 80 NORTH AMERICA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 81 NORTH AMERICA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 82 NORTH AMERICA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 83 NORTH AMERICA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 84 NORTH AMERICA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 85 NORTH AMERICA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 86 NORTH AMERICA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 87 NORTH AMERICA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 88 NORTH AMERICA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 89 NORTH AMERICA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 90 NORTH AMERICA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 91 NORTH AMERICA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 92 NORTH AMERICA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 93 NORTH AMERICA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 94 NORTH AMERICA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 95 NORTH AMERICA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 96 NORTH AMERICA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 97 NORTH AMERICA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 98 NORTH AMERICA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 99 U.S. HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 100 U.S. CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 101 U.S. DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 102 U.S. CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 103 U.S. GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 104 U.S. REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 105 U.S. STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 106 U.S. OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 107 U.S. HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 108 U.S. HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 109 U.S. SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 110 U.S. HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 111 U.S. HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 112 U.S. QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 113 U.S. Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 114 U.S. HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 115 U.S. CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 116 U.S. METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 117 U.S. INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 118 U.S. MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 119 U.S. NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 120 U.S. HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 121 U.S. HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 122 U.S. HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 123 CANADA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 124 CANADA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 125 CANADA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 126 CANADA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 127 CANADA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 128 CANADA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 129 CANADA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 130 CANADA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 131 CANADA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 132 CANADA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 133 CANADA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 134 CANADA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 135 CANADA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 136 CANADA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 137 CANADA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 138 CANADA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 139 CANADA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 140 CANADA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 141 CANADA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 142 CANADA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 143 CANADA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 144 CANADA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 145 CANADA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 146 CANADA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 147 MEXICO HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 148 MEXICO CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 149 MEXICO DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 150 MEXICO CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 151 MEXICO GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 152 MEXICO REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 153 MEXICO STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 154 MEXICO OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)
TABLE 155 MEXICO HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)
TABLE 156 MEXICO HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 157 MEXICO SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)
TABLE 158 MEXICO HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)
TABLE 159 MEXICO HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 160 MEXICO QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 161 MEXICO Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 162 MEXICO HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 163 MEXICO CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 164 MEXICO METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 165 MEXICO INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 166 MEXICO MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 167 MEXICO NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)
TABLE 168 MEXICO HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 169 MEXICO HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)
TABLE 170 MEXICO HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA HEALTH SCREENING MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA HEALTH SCREENING MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA HEALTH SCREENING MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA HEALTH SCREENING MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA HEALTH SCREENING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA HEALTH SCREENING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA HEALTH SCREENING MARKET: MARKET DISTRIBUTION CHANNEL COVERAGE GRID
FIGURE 9 NORTH AMERICA HEALTH SCREENING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 11 HIGH PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE NORTH AMERICA HEALTH SCREENING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 CHOLESTROL TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA HEALTH SCREENING MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA HEALTH SCREENING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA HEALTH SCREENING MARKET
FIGURE 15 PREVALENCE OF CHRONIC DISEASES
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)
FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLION)
FIGURE 18 EUROPE AGING POPULATION (IN MILLION)
FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLION)
FIGURE 20 NORTH AMERICA HEALTH SCREENING MARKET: BY TEST TYPE, 2020
FIGURE 21 NORTH AMERICA HEALTH SCREENING MARKET: BY TEST TYPE, 2021-2028 (USD MILLION)
FIGURE 22 NORTH AMERICA HEALTH SCREENING MARKET: BY TEST TYPE, CAGR (2021-2028)
FIGURE 23 NORTH AMERICA HEALTH SCREENING MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 24 NORTH AMERICA HEALTH SCREENING MARKET: BY PANEL TYPE, 2020
FIGURE 25 NORTH AMERICA HEALTH SCREENING MARKET: BY PANEL TYPE, 2021-2028 (USD MILLION)
FIGURE 26 NORTH AMERICA HEALTH SCREENING MARKET: BY PANEL TYPE, CAGR (2021-2028)
FIGURE 27 NORTH AMERICA HEALTH SCREENING MARKET: BY PANEL TYPE, LIFELINE CURVE
FIGURE 28 NORTH AMERICA HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2020
FIGURE 29 NORTH AMERICA HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2021-2028 (USD MILLION)
FIGURE 30 NORTH AMERICA HEALTH SCREENING MARKET: BY PACKAGE TYPE, CAGR (2021-2028)
FIGURE 31 NORTH AMERICA HEALTH SCREENING MARKET: BY PACKAGE TYPE, LIFELINE CURVE
FIGURE 32 NORTH AMERICA HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2020
FIGURE 33 NORTH AMERICA HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2021-2028 (USD MILLION)
FIGURE 34 NORTH AMERICA HEALTH SCREENING MARKET: BY SAMPLE TYPE, CAGR (2021-2028)
FIGURE 35 NORTH AMERICA HEALTH SCREENING MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 36 NORTH AMERICA HEALTH SCREENING MARKET: BY TECHNOLOGY, 2020
FIGURE 37 NORTH AMERICA HEALTH SCREENING MARKET: BY TECHNOLOGY, 2021-2028 (USD MILLION)
FIGURE 38 NORTH AMERICA HEALTH SCREENING MARKET: BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 39 NORTH AMERICA HEALTH SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 40 NORTH AMERICA HEALTH SCREENING MARKET: BY CONDITION, 2020
FIGURE 41 NORTH AMERICA HEALTH SCREENING MARKET: BY CONDITION, 2021-2028 (USD MILLION)
FIGURE 42 NORTH AMERICA HEALTH SCREENING MARKET: BY CONDITION, CAGR (2021-2028)
FIGURE 43 NORTH AMERICA HEALTH SCREENING MARKET: BY CONDITION, LIFELINE CURVE
FIGURE 44 NORTH AMERICA HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 45 NORTH AMERICA HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 46 NORTH AMERICA HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 47 NORTH AMERICA HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 48 NORTH AMERICA HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2020
FIGURE 49 NORTH AMERICA HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2021-2028 (USD MILLION)
FIGURE 50 NORTH AMERICA HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, CAGR (2021-2028)
FIGURE 51 NORTH AMERICA HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, LIFELINE CURVE
FIGURE 52 NORTH AMERICA HEALTH SCREENING MARKET: SNAPSHOT (2020)
FIGURE 53 NORTH AMERICA HEALTH SCREENING MARKET: BY COUNTRY (2020)
FIGURE 54 NORTH AMERICA HEALTH SCREENING MARKET: BY COUNTRY (2021 & 2028)
FIGURE 55 NORTH AMERICA HEALTH SCREENING MARKET: BY COUNTRY (2020 & 2028)
FIGURE 56 NORTH AMERICA HEALTH SCREENING MARKET: BY TEST TYPE (2021-2028)
FIGURE 57 NORTH AMERICA HEALTH SCREENING MARKET: COMPANY SHARE 2020(%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.